Data / Form D filings / PROTEA BIOSCIENCES INC
PROTEA BIOSCIENCES INC: Form D filings
PROTEA BIOSCIENCES INC, a biotechnology company in Morgantown, WV, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on May 5, 2011, reports $1.1 million sold of a $5 million offering to 8 investors.
Find out what PROTEA BIOSCIENCES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 955 Hartman Run Road, Suite 210, Morgantown, WV, 26507
- Phone
- (304) 292-2226
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1194490
The full lists. Form D filings in West Virginia: 24 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 5, 2011 | New notice | $5,000,000 | $1,050,000 | $3,950,000 | 8 | Apr 28, 2011 | sec.gov |
| Jan 14, 2011 | Amendment | Indefinite | $7,490,000 | Indefinite | 84 | Aug 3, 2009 | sec.gov |
| Aug 12, 2009 | New notice | $4,800,000 | $180,000 | $4,620,000 | 3 | Aug 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen Turner | Executive Officer, Director | |
| Harris Leo | Director | |
| Steve Antoline | Director | |
| Scott Segal | Director | |
| Daniel Flynn | Director | |
| Thomas Clark | Director | |
| Stanley Hostler | Executive Officer, Director | |
| Jesse Ayers | Executive Officer | |
| Milan Puskar | Director | |
| Roderick Jackson | Director | |
| Ed Roberson | Director |
Every Form D from the week of May 2, 2011 · All recent filings in West Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PROTEA BIOSCIENCES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.